BioNTech SE (22UA) — Strategic Asset Allocation Index
BioNTech SE (22UA) has a Strategic Asset Allocation Index of 12.2% as of March 2026. Strategic assets (PP&E of €- plus long-term investments of €2.28 Billion) total €2.28 Billion, measured against net assets of €18.70 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
BioNTech SE Strategic Asset Allocation Index (2016–2025)
This chart shows how BioNTech SE's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2025. As of March 2026, the index stands at 12.2%, representing strategic assets of €2.28 Billion against net assets of €18.70 Billion EUR. Explore 22UA cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for BioNTech SE (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for BioNTech SE from 2016 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 22UA market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 13.3% | €2.55 Billion | €- | €2.55 Billion | €19.22 Billion | ▲ +6.8 pp |
| 2024 | 6.5% | €1.25 Billion | €- | €1.25 Billion | €19.41 Billion | ▲ +0.7 pp |
| 2023 | 5.8% | €1.18 Billion | €- | €1.18 Billion | €20.25 Billion | ▲ +5.4 pp |
| 2022 | 0.4% | €80.20 Million | €- | €80.20 Million | €20.06 Billion | ▼ -4.2 pp |
| 2021 | 4.6% | €541.70 Million | €520.40 Million | €21.30 Million | €11.89 Billion | ▼ -19.2 pp |
| 2020 | 23.8% | €326.00 Million | €326.00 Million | €0.00 | €1.37 Billion | ▼ -6.2 pp |
| 2019 | 30.0% | €148.06 Million | €148.06 Million | €0.00 | €493.49 Million | ▼ -13.4 pp |
| 2018 | 43.4% | €115.98 Million | €115.97 Million | €18.00K | €267.00 Million | ▲ +43.2 pp |
| 2016 | 0.2% | €66.00K | €- | €66.00K | €31.86 Million | — |